Evommune EVMN Distributions from equity method investments

Distributions from equity method investments at other companies

Cabot CorporationCBT

$1M-91.7%

HES

Hess MidstreamHESM

$4.7M-4.1%

Atmus Filtration TechnologiesATMU

$6M+216%

EPR PropertiesEPR

$0-100%

Nexstar Media Group, Inc.NXST

$84M-26.3%

Dolby Laboratories, Inc.DLB

$5.28M+479%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's distributions from equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's distributions from equity method investments?: Evommune (EVMN) reported distributions from equity method investments of $77.05K in Q1 2026.
What does distributions from equity method investments mean?: Cash distributions received from equity method investees as dividend payments or capital returns.